Anthony El-Khoueiry(@DrElkhoueiry) 's Twitter Profileg
Anthony El-Khoueiry

@DrElkhoueiry

ID:1727505096

calendar_today04-09-2013 04:13:04

174 Tweets

606 Followers

231 Following

Jun Gong(@jgong15) 's Twitter Profile Photo

Anthony El-Khoueiry on 4-yr OS of STRIDE in and value of priming dose of anti-CTLA4, emerging /VEGF & into earlier settings ( ), novel -based & targeted tx’s in

5th Annual Cedars-Sinai Tumor Conf cedars.cloud-cme.com/course/courseo…

OncoAlert

@DrElkhoueiry on 4-yr OS of STRIDE in #HCC and value of priming dose of anti-CTLA4, emerging #1L #IO/VEGF & into earlier #HCC settings (#EMERALD), novel #IO-based & targeted tx’s in #biliarytractccancer 5th Annual @CedarsSinai #GI Tumor Conf cedars.cloud-cme.com/course/courseo… @OncoAlert
account_circle
Cure GI Cancers(@RueschCenter) 's Twitter Profile Photo

Important discussion on hepatobiliary cancer: the new frontiers of immunotherapy in hepatocellular carcinoma and emerging actionable targets in biliary tract cancers with Anthony El-Khoueiry, Dr. Diana L Hanna and John Marshall at . USC Norris Comprehensive Cancer Center Keck Medicine of USC PER

Important discussion on hepatobiliary cancer: the new frontiers of immunotherapy in hepatocellular carcinoma and emerging actionable targets in biliary tract cancers with @DrElkhoueiry, Dr. Diana L Hanna and @marshalj23 at #SOGO. @uscnorris @KeckMedicineUSC @gotoPER
account_circle
Jun Gong(@jgong15) 's Twitter Profile Photo

Please join Dr. Andrew Hendifar Arsen Osipov, MD & us at Cedars-Sinai 5th Annual Tumor Conf w/a stellar line-up of speakers in Dr. Marwan G. Fakih Dr. Randy Hecht, Dr. Philip Philip, Dr. Ed Wolin Anthony El-Khoueiry Tatiana Prowell, MD

3/23/24 hybrid event
Register at:

cedars.cloud-cme.com/course/courseo…

Please join @DrHendifar @DrArsenOsipov & us at @CedarsSinai 5th Annual #GI Tumor Conf w/a stellar #KOL line-up of speakers in #oncology @mgfakih Dr. Randy Hecht, Dr. Philip Philip, Dr. Ed Wolin @DrElkhoueiry @tmprowell 3/23/24 hybrid event Register at: cedars.cloud-cme.com/course/courseo…
account_circle
Anthony El-Khoueiry(@DrElkhoueiry) 's Twitter Profile Photo

Team bonding at Stand Up to Cancer Scientific Summit 2024! Our USC Norris Comprehensive Cancer Center team presented an update on our SU2C funded projects to increase diversity in early phase trials! Thank you SU2C for a great meeting! SU2Cscience USC Norris Comprehensive Cancer Center Chanita Halbert

Team bonding at Stand Up to Cancer Scientific Summit 2024! Our USC Norris Comprehensive Cancer Center team presented an update on our SU2C funded projects to increase diversity in early phase trials! Thank you SU2C for a great meeting! @SU2Cscience @uscnorris @chanita_halbert
account_circle
Anjana Pillai(@AnjanaPillaiMD) 's Twitter Profile Photo

T-13 days for HCC-LIVE Conference . Registration is filling up fast!! Come join us for great discussions, heated debates, up to date treatment paradigms and the donut wall 🍩 Amit G Singal Anthony El-Khoueiry Riad Salem Julie Heimbach

account_circle
Tanios Bekaii-Saab, MD(@GIcancerDoc) 's Twitter Profile Photo

Join our outstanding Mayo Clinic Comprehensive Cancer Center and guest faculty on Nov 10-11 in Las Vegas (or via livestream) for 2023 Mayo Clinic Symposium! Registration information and the program schedule are available here:   tinyurl.com/mvjeuc3w

Join our outstanding @MayoCancerCare and guest faculty on Nov 10-11 in Las Vegas (or via livestream) for 2023 Mayo Clinic #livercancer #pancreascancer #cholangiocarcinoma Symposium! Registration information and the program schedule are available here:   tinyurl.com/mvjeuc3w
account_circle
HCC-LIVE Conference(@HCCLIVEConf) 's Twitter Profile Photo

Course Directors invite the submission of abstracts regarding advances in therapeutics, diagnosis, pathogenesis, and management of hepatocellular carcinoma. Deadline: December 15, 2023.
hcc-live.org/call-for-abstr…
LIVE Julie Heimbach Anthony El-Khoueiry Anjana Pillai Amit G Singal

Course Directors invite the submission of abstracts regarding advances in therapeutics, diagnosis, pathogenesis, and management of hepatocellular carcinoma. Deadline: December 15, 2023. hcc-live.org/call-for-abstr… #HCCLIVE #HCC @JulieHeimbach @DrElkhoueiry @AnjanaPillaiMD @docamitgs
account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

Looking forward to a great discussion on liver cancer with Katie Kelley, Anthony El-Khoueiry and Neil Love
Research to Practice
Breakfast with the investigators “hepatobiliäry Cancers”
ESMO - Eur. Oncology EASL Education ILCA OncoAlert

Looking forward to a great discussion on liver cancer with Katie Kelley, @DrElkhoueiry and Neil Love Research to Practice Breakfast with the investigators “hepatobiliäry Cancers” @myESMO @EASLedu @ILCAnews @OncoAlert #livertwitter
account_circle
Keck School of Medicine of USC(@KECKSchool_USC) 's Twitter Profile Photo

Anthony El-Khoueiry, MD, and Chanita Hughes-Halbert, PhD, discuss their role within the Stand Up To Cancer (Stand Up To Cancer) 4-team initiative, focusing on diversity in early-phase clinical trials. Anthony El-Khoueiry @Chanita_Halbert OncLive.com
onclive.com/view/drs-el-kh…

account_circle
USC Norris Comprehensive Cancer Center(@uscnorris) 's Twitter Profile Photo

We are excited to announce that USC Norris is collaborating with Auransa Inc. on a phase 1 clinical trial to evaluate a new kind of treatment for cancers of the liver and solid tumors with liver dominant disease. Learn more here:
uscnorriscancer.usc.edu/2023/03/23/usc…

We are excited to announce that USC Norris is collaborating with Auransa Inc. on a phase 1 clinical trial to evaluate a new kind of treatment for cancers of the liver and solid tumors with liver dominant disease. Learn more here: uscnorriscancer.usc.edu/2023/03/23/usc… #livercancer
account_circle
Anthony El-Khoueiry(@DrElkhoueiry) 's Twitter Profile Photo

Honored to lead one of four teams funded by SU2C to increase diversity in early phase clinical trials. Looking forward to working with my co-leader Chanita Halbert and an amazing group of colleagues USC Norris Comprehensive Cancer Center Jorge Nieva Jennifer Tsui Anastasia Martynova, MD bit.ly/3lfoIjb

account_circle
Benjamin Weinberg, MD, FACP(@benweinbergmd) 's Twitter Profile Photo

IMbrave151 phase 2 study of gem/cis/atezo/bev vs. gem/cis/atezo/placebo in advanced ➡️ improved PFS with bev HR 0.76, same ORR ~24%, possible OS benefit Anthony El-Khoueiry $GENE
ASCO Cure GI Cancers OncoAlert

IMbrave151 phase 2 study of gem/cis/atezo/bev vs. gem/cis/atezo/placebo in advanced #biliarycancer➡️ improved PFS with bev HR 0.76, same ORR ~24%, possible OS benefit @DrElkhoueiry $GENE #GI23 @ASCO @RueschCenter @OncoAlert
account_circle
ILSON David(@ILSONDavid) 's Twitter Profile Photo

Napoli trial indicates irinotecan triplet regimen Nalirinox is superior to gem nab paclitaxel. The debate about first line treatment in pancreatic cancer is over.

Napoli trial indicates irinotecan triplet regimen Nalirinox is superior to gem nab paclitaxel. The debate about first line treatment in pancreatic cancer is over.
account_circle